Cargando…
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)
BACKGROUND AND PURPOSE: The ability of low dose radiotherapy (LDRT) to control the unprecedented cytokine release associated with COVID-19 pathogenesis has been an area of widespread research since the COVID pandemic. It has not been studied adequately whether the anti-inflammatory effect of LDRT pr...
Autores principales: | Ganesan, Govindaraj, Ponniah, Sasipriya, Sundaram, Vivek, Marimuthu, Praveen Kumar, Pitchaikannu, Venkatraman, Chandrasekaran, Manikandan, Thangarasu, Janakiraman, Kannupaiyan, Gunasekaran, Ramamoorthy, Prabhu, Thangaraj, Brindha, Govindaraj, Harshavardhanan Sasipriya, Raguram, Shree Vaishnavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709793/ https://www.ncbi.nlm.nih.gov/pubmed/34958809 http://dx.doi.org/10.1016/j.radonc.2021.12.024 |
Ejemplares similares
-
Response to “Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
por: Ganesan, Govindaraj, et al.
Publicado: (2022) -
Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India
por: Ganesan, Govindaraj, et al.
Publicado: (2021) -
Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India”
por: Ganesan, Govindaraj, et al.
Publicado: (2022) -
Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
por: Ozyurek, Yasin, et al.
Publicado: (2022) -
Increasing sustainable cataract services in sub-Saharan Africa: an experimental initiative
por: Karumanchi, Sasipriya M, et al.
Publicado: (2014)